Research Presentation Sessions: Genitourinary
RPS 1107 - What is best to detect prostate cancer?
Lectures
1
Introduction by the moderator
02:00Olivio F. Donati, Zurich / CH
2
Differentiation of benign prostate hyperplasia from prostate cancer based on the combination of radiomics signatures of the transition zone in mpMRI and PSA-level elevations
08:00Benedict Oerther, Freiburg / DE
3
A randomised controlled trial on the role of MRI for prostate cancer screening: prostate cancer secondary screening in Sapienza, PROSA preliminary results
08:00Emanuele Messina, Rome / IT
4
Biparametric versus multiparametric MR imaging of prostate imaging reporting and data system version 2.1 in detection of prostate cancer
08:00Ahmed Mohamed Ali Khalil Elhendy, Mansoura / EG
5
Towards the definition of radiomics and clinical indices to enhance malignant tumour diagnosis in PI-RADS 4 and 5 lesions
08:00Paolo Niccolò Franco, Bergamo / IT
6
Artificial intelligence and multiparametric (mp)MRI in the assessment of prostate cancer (PCa) aggressiveness
08:00Laura Mercatelli, Firenze / IT
7
An impact of prior treatment with 5-alpha inhibitor on apparent diffusion coefficient values in prostate cancer differentiation
08:00Yulian Mytsyk, Lviv / UA
8
EPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multi-parametric magnetic resonance imaging
08:00Giulio Antonino Strazzarino, Ivrea / IT
9
The role of ADC values in the distinction between clinically significant PCa, insignificant PCa and HPIN lesions by 3T MRI
08:00Georgios Agrotis, Larisa / GR
